ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Gayatri BioOrganics Limited held its 35th Annual General Meeting on September 23, 2026, where shareholders adopted financial statements and approved the company's name change.
Gayatri BioOrganics Limited scheduled its 35th Annual General Meeting for September 23, 2026. The company also submitted its Annual Report for the FY 2025-26.
Venkata Sandeep Kumar Reddy Tikkavarapu has resigned from his position as Chairman and Non-Executive Director of Gayatri BioOrganics Limited, effective August 5, 2026.
Gayatri BioOrganics Ltd reported revenue from operations of ₹2.3 Cr and a net loss of ₹0.1 Cr for Q1 FY27.
Gayatri BioOrganics Ltd has scheduled a board meeting on 04.08.2026 to consider and approve the un-audited financial results for the quarter ended 30.06.2026.
Gayatri BioOrganics Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulatory requirements.
Gayatri Bioorganics Limited filed its Annual Secretarial Compliance Report for the financial year 2026. The report confirms overall regulatory adherence with minor observations noted by auditors.
Gayatri BioOrganics Ltd re-submitted its audited financial results for FY26 to rectify typographical errors. The company confirmed no impact on reported financial performance or profitability.
Gayatri BioOrganics Ltd reported a net loss of ₹42 Cr for Q4 FY26.
Gayatri BioOrganics reported audited FY26 results with total assets of ₹1.72 Crore. The company appointed M/s. Vas & Co. as internal auditors for FY27.
Gayatri Bioorganics scheduled a board meeting on May 19, 2026, to approve audited financial results. This advance notice provides transparency for upcoming corporate reporting.
Gayatri Bioorganics Limited submitted its annual disclosure confirming it does not meet the SEBI criteria for identification as a Large Corporate for FY 2025-26. The company reported zero mandatory debt borrowing and no penalties for the period.
Gayatri Bioorganics Limited confirmed it does not qualify as a 'Large Corporate' for FY 2026-27 under SEBI norms. The company's outstanding long-term borrowings stood at ₹2.07 Crore as of March 31, significantly below the ₹1,000 Crore threshold required for the mandatory debt sourcing framework.
Gayatri BioOrganics Ltd has postponed its Board Meeting originally scheduled for April 15, 2026. The meeting was intended to consider a proposal for capital reduction. A rescheduled date will be communicated to the exchange later.
Gayatri BioOrganics Ltd has scheduled a Board Meeting on April 15, 2026, to consider a Scheme of Reduction of Share Capital. Additionally, the trading window for dealing in the company's securities is closed from April 1, 2026, until 48 hours after the declaration of audited financial results.